electroCore Stock (NASDAQ:ECOR)


Chart

Previous Close

$6.62

52W Range

$5.32 - $19.49

50D Avg

$13.28

200D Avg

$10.33

Market Cap

$42.22M

Avg Vol (3M)

$152.66K

Beta

0.84

Div Yield

-

ECOR Company Profile


electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

73

IPO Date

Jun 22, 2018

Website

ECOR Performance


Latest Earnings Call Transcripts


Q2 22Aug 07, 22 | 8:01 AM
Q1 22May 08, 22 | 10:36 PM
Q4 21Mar 10, 22 | 10:34 PM

Peer Comparison


TickerCompany
SSKNSTRATA Skin Sciences, Inc.
IRIXIRIDEX Corporation